3

FORM 3 SUBMISSION

Company: Lineage Cell Therapeutics, Inc.
Filed: September 27, 2013
Period of Report: September 27, 2013
Accession Number: 0001209191-13-046021

View Document ↗ View on SEC.gov ↗